23.6 C
Munich
Wednesday, May 18, 2022

The Power Play by The Market Herald Releases Interviews With Else Nutrition, Ayurcann Holdings, and Resverlogix – Investing News Network

Must read

The Power Play by The Market Herald has announced the release of new interviews with Else Nutrition, Ayurcann Holdings, and Resverlogix on their latest news
The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company’s latest press release through exclusive insights and interviews with company executives.
Else Nutrition (TSX:BABY) concludes successful preclinical study of plant-based infant formula
Else Nutrition (BABY) has concluded a preclinical study on its plant-based, soy-free infant formula. This study demonstrates the safety and nutrient bioavailability of the Else infant formula. Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition sat down with Shoran Devi to discuss the news.
For the full interview with Hamutal Yitzhak and to learn more about Else Nutrition’s news, click here.
Ayurcann Holdings (CSE:AYUR) reports record sales and positive operating income in Q2, 2021
Ayurcann Holdings Corp. (AYUR) has reported financial and operating results for its second-quarter ending December 31, 2021. Ayurcann reported increased revenues of 106 per cent and increased gross margins of 500 per cent YoY. Igal Sudman, Co-Founder and CEO of Ayurcann sat down with Shoran Devi to discuss the results.
For the full interview with Igal Sudman and to learn more about Ayurcann Holdings’ results, click here.
Resverlogix (TSX:RVX) steps up Phase 2b study for COVID-19 treatment
Resverlogix (RVX) has initiated the first Brazilian and a second Canadian site for its Phase 2b clinical trial for COVID-19 treatment. The study aims to evaluate the safety and efficacy of Canadian-developed apabetalone as a potential oral treatment for COVID-19. Donald J. McCaffrey, President & CEO of Resverlogix sat down with Shoran Devi to discuss the study.
For the full interview with Donald McCaffrey and to learn more about Resverlogix’s study, click here.
Interviews for The Power Play by The Market Herald are released daily. To learn more about the companies featured in The Power Play or to explore our other interviews visit The Power Play by The Market Herald.
About The Market Herald
The Market Herald Canada is the leading source of authoritative breaking stock market news for self-directed investors. Our team of Canadian markets reporters, editors and technologists covers the entire listed company universe in Canada. We cover over 3,985 businesses, their people, their investors, and their customers. We write the stories that move the Canadian capital markets.
DISCLAIMER: Report Card Canada Media Ltd. (“Report Card”) is a wholly-owned subsidiary of Market Herald Limited, an Australian company (“Market Herald”). Report Card is not an advisory service, and does not offer, buy, sell, or provide any other rating, analysis or opinion on the securities we discuss. We are retained and compensated by the companies that we provide information on to assist them with making information available to the public. All information available on themarketherald.ca and/or this press release should be considered as commercial advertisement and not an endorsement, offer or recommendation to buy or sell securities. Report Card is not registered with any financial or securities regulatory authority in any province or territory of Canada, will not be performing any registerable activity as defined by the applicable regulatory bodies and do not provide nor claim to provide investment advice or recommendations to any visitor of this site or readers of any content on or originating from themarketherald.ca. Market Herald and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Market Herald’s affiliates. In such instances, Market Herald and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Market Herald and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize any conflict. All the information on this document and/or the website – themarketherald.ca – is published in good faith and for general information purpose only. Report Card does not make any warranties about the completeness, reliability, and accuracy of this information. Any action you take upon the information you find on this document and/or website (themarketherald.ca) is strictly at your own risk. Report Card will not be liable for any losses and/or damages in connection with the use of our website. From our website, you can visit other websites by following hyperlinks to such external sites. While we strive to provide only quality links to useful and ethical websites, we have no control over the content and nature of these sites. These links to other websites do not imply a recommendation for all the content found on these sites. Site owners and content may change without notice and may occur before we have the opportunity to remove a link which may have gone ‘bad’. Please be also aware that when you leave our website, other sites may have different privacy policies and terms which are beyond our control. Please be sure to check the Privacy Policies of these sites as well as their “Terms of Service” before engaging in any business or uploading any information.
CONTACT:
The Market Herald
Brianna Anthony
[email protected]
themarketherald.ca
SOURCE: The Market Herald
News Provided by ACCESSWIRE via QuoteMedia

In an industry that was previously reliant on grower companies, more fully integrated companies delivering multiple verticals in cannabis processing and production offer an unparalleled investment opportunity that stands out from the rest.
Ayurcann (CSE:AYUR) is a leading B2B post-harvest solution and provider focused on providing scalable custom processes and pharma-grade products to the medical cannabis industry in Canada. Ayurcann is focused on becoming the partner of choice for leading Canadian cannabis brands by delivering best-in-class, proprietary services, including ethanol extraction, formulation, product development and custom manufacturing.

The company offers a two-tier business model of services and production. The manufacturing vertical offers three production divisions specializing in expert cannabis-based extraction and refinement, high-quality bulk oil sales and white label manufacturing. Ayurcann currently extracting approximately 1,500 kilograms a week of product and has the capacity to process up to 200,000 kilograms of dry cannabis annually.

Additionally, its proprietary Ayurcann Marketplace offers a premium selection of cannabis and hemp products, including tinctures, vapes and topicals for personalized care.
The company operates out of Pickering, Ontario, allowing Ayurcann to leverage easy access to licensed producers and other cannabis participants in the region. It also holds Processing and Research Licences issued by Health Canada.
Ayurcann’s management team consists of innovators in the cannabis and corporate space that bring together years of experience in business development, finance, post-harvest production and quality control. This leadership and their vested interest in the success of

Ayuracann’s production division, offers full end-to-end outsourcing services, including proprietary product research & development, cannabis extraction & refinement and final production formulation & fulfillment. The company leverages experience, expertise and a robust network to assist clients across Canada and the world.
Ayurcann provides multiple verticals in cannabis production. These premier services include well-engineered extraction and refinement, high-quality bulk oil sales for manufacturers and brands and white label manufacturing for product development to commercialization.

The Ayurcann Marketplace offers a personalized level of care through its high-quality, safe and consistent medicinal cannabis tailored to patient needs. This robust selection of premier cannabis products includes tinctures, vapes and topicals.
The company leverages an impressive library of terpenes and utilizes flexible production and concentration processes to address unique customer needs.

Igal Sudman is a business development specialist who brings over 20 years of experience in various industries, from real estate development to technology and cannabis. Sudman understands the objectives and requirements needed to scale companies from seed to exit, having founded and developed businesses featured on the Canadian Profit 50.
Roman Buzaker is a corporate strategist with a specialty in management and operational engineering. He has experience in industries such as logistics, digital marketing and business consulting. Buzaker managed the expansion and the development of various online and brick-and-mortar companies from single-location operations to multi-locational franchises nationwide.
Jaspreet Bhatia is a quality control manager with a Ph.D. Degree in Chemistry. She has over five years of quality control experience and in-depth knowledge of GMP, GLP, Cannabis regulations and quality guidelines. She possesses extensive knowledge and expertise in technical writing, product development and product release
Raj Virk is a quality system expert with over 18 years of experience in the pharmaceutical industry. Virk is highly skilled and experienced in GMP, GPP, quality investigations, deviation reports, technical writing and quality audits.
He holds a Master’s Degree in science along with a Postgraduate Diploma in Pharmaceutical Quality Assurance.
Aaron Meckler is a seasoned corporate finance professional with over eight years of experience in public and private equity, covering real estate, growth-stage ventures, public listings and M&A transactions. He has acted in a CFO capacity for public and private companies and currently sits on the board of directors for two reporting issuers, Stralak Resources and Brandenburg Energy.
Alison Gordon has worked in all verticals of this emerging market. As the founder of 48North Cannabis Corp, Gordon was the first female CEO of a public cannabis company. Gordon developed strategies for patient acquisition, brand awareness, investor relations, customer service, physician outreach, and has traveled all over North America, applying her vast marketing experience to evaluating investment and acquisition.
Gordon’s competitive advantage is her hands-on experience in production, distribution and retail across several vastly different markets throughout the US and Canada.
David Hackett brings more than 20 years of financial and management leadership. He has overseen the growth of several start-up companies, including dealing with operations, technology, regulatory reporting, corporate governance, public financing and M&A activity.
Hackett is a CPA and CA and holds an MBA from the Richard Ivey School of Business at the Western University.
Maor Shayit is a seasoned and ambitious operation & marketing professional with more than 15 years of experience driving national, sales and P&L growth across a wide range of industries, including retail, telecommunications and cannabis.
Shayit has successfully built and improved operations and marketing departments for the last three years for an emerging Ontario-based licensed producer as a COO.
Ayurcann Holdings Corp. ( CSE:AYUR OTCQB: AYUR F FSE:3ZQ0 ) (” Ayurcann ” or the ” C ompany “), a leading Canadian cannabis extraction company specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 and 3.0 products in the medical and recreational market, is pleased to report its financial and operating results for its second quarter ending December 31, 2021. All figures reported are in Canadian dollars.
HIGHLIGHTS OF THE QUARTER ENDED DECEMBER 3 1 , 2021:
Igal Sudman, Chief Executive Officer of Ayurcann, said, “this quarter we have shown and have proven again that Ayurcann is able to maintain a profitable business and expand its market share. Ayurcann works diligently to serve its clients and continues to grow its revenues, while keeping an eye on its bottom line.”
Mr. Sudman added: “we are thrilled to see our revenues grow at a steady pace while maintaining strong margins and being responsible to our shareholders. We can confidently say that we fully expect to show continued growth and build on our momentum.”
About Ayurcann
Ayurcann is a leading post-harvest solution provider with a focus on providing and creating custom processes and pharma grade products for the adult use and medical cannabis industry in Canada. Ayurcann is striving to become a partner of choice for leading Canadian and international cannabis brands by providing best-in-class, proprietary services including extraction, formulation, product development and custom manufacturing.
For additional information, please contact:
Ayurcann Holdings Corp.
Igal Sudman, Chief Executive Officer
905-492-3322
[email protected]
Investor Relations:
Email: [email protected]
The Company’s unaudited interim financial statements and management’s discussion and analysis for the three-month and six-month periods ended December 31, 2021, are available under the Company’s SEDAR profile at www.sedar.com .
Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking statements” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking statements. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein include, but are not limited to, statements regarding Company generating further sales with its exclusive partnership brands; the Company continuing to grow and show positive operating income; and the ability of the Company to become the partner of choice for leading Canadian cannabis brands.
Forward-looking information in this news release are based on certain assumptions and expected future events, namely: the Company will expand and be able to maintain production capacity; the Company ‘s ability to continue as a going concern; continued approval of the Company ‘s activities by the relevant governmental and/or regulatory authorities; the continued growth of the Company ; the Company generating further sales with its exclusive partnership brands; the Company continuing to show positive operating income; and the Company becoming the partner of choice for leading Canadian cannabis brands.
These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the Company ‘s inability to expand and/or maintain production capacity; the potential inability of the Company to continue as a going concern; the risks associated with the cannabis industry in general; increased competition in the cannabis extraction market; the potential future unviability of the cannabis market; risks associated with potential governmental and/or regulatory action with respect to the cannabis industry ; the Company ‘s inability to generate further sales with its exclusive partnership brands; the Company being unable to grow and / or show positive operating income in future quarters and the inability of the Company to become the partner of choice for leading Canadian cannabis brands and other risks, uncertainties and factors set out under the heading “Risk Factors” in the Company’s management’s discussion and analysis dated February 22 , 202 2 (“MD&A”) and filed with Canadian securities regulators available on the Company’s issuer profile on SEDAR at www.sedar.com.
Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.
Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect the Company ‘s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the United States Securities Act of 1933, as amended, and applicable state securities laws.

News Provided by GlobeNewswire via QuoteMedia

Ayurcann Holdings Corp. (CSE : AYUR) (OTCQB: AYURF) (FSE: 3ZQ0) (” Ayurcann ” or the ” Corporation “), a leading Canadian cannabis extraction company specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 products in the medical and recreational market, is pleased to announce the launch of their high potency THC branded “Fuego” vapes into Alberta . This is the 5 th province over the last 4 months that Ayurcann has entered in Canada . Ayurcann will launch their line of Fuego products through the Alberta Gaming, Liquor & Cannabis Commission (the ” AGLC “). Products will be made available through authorized retailers across Alberta .

“Fuego” branded vapes has been a best seller across various Canadian markets with repeat orders coming in on a monthly basis. With the introduction of one of the highest concentrations of active cannabinoids on the market in this format, Ayurcann’s strategy is to expand market share in extract and extract derivatives while providing exceptional products to consumers.
“We are thrilled to announce Fuego’s initial entrance into Alberta , where we are optimistic about its market potential as an industry leading value brand line. We have been successfully selling in NB, MB, SK and ON and believe that the interest from consumers and retailers will help set the standard for vape products in Alberta ,” states Igal Sudman , Chief Executive Officer of Ayurcann.
OTCQB Symbol Change
Ayurcann is also pleased to announce that it has received approval from OTC Markets Group Inc. (the ” OTCQB “) to change its symbol to “AYURF” effective as of market open, January 27, 2022 .
About OTCQB
The OTCQB operates the OTCQB ® Best Market, OTCQB ® Venture Market and Pink ® Open Market for 11,000 U.S. and global securities. To learn more about the OTCQB, please visit www.otcmarkets.com .
About Ayurcann
Ayurcann is a leading post-harvest solution provider with a focus on providing and creating custom processes and pharma grade products for the adult use and medical cannabis industry in Canada . Ayurcann is striving to become a partner of choice for leading Canadian and international cannabis brands by providing best-in-class, proprietary services including extraction, formulation, product development and custom manufacturing.
Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking statements” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking statements. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein include, but are not limited to, statements regarding: the Corporation’s commencement of sales of its high potency THC branded “Fuego” vapes in the Province of Alberta ; the Corporation’s strategy to expand market share in extract and extract derivatives while providing exceptional products to consumers ; the Corporation’s ability to meet the requirements necessary to remain listed on the OTCQB; and the ability of the Corporation to become the partner of choice for leading Canadian cannabis brands.
Forward-looking information in this news release are based on certain assumptions and expected future events, namely: the Corporation will expand and be able to maintain production capacity; the Corporation’s ability to continue as a going concern; continued approval of the Corporation’s activities by the relevant governmental and/or regulatory authorities; the continued growth of the Corporation; the Corporation receiving continued approval from the AGLC and other necessary approvals required for the sales of its high potency THC branded “Fuego” vapes in the Province of Alberta ; the Corporation’s successful implementation of its strategy to expand market share in extract and extract derivatives while providing exceptional products to consumers ; the Corporation’s continuing ability to meet the requirements necessary to remain listed on the OTCQB; and the ability of the Corporation to become the partner of choice for leading Canadian cannabis brands.
These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the Corporation’s inability to expand and/or maintain production capacity; the potential inability of the Corporation to continue as a going concern; the risks associated with the cannabis industry in general; increased competition in the cannabis extraction market; the potential future unviability of the cannabis market; risks associated with potential governmental and/or regulatory action with respect to the cannabis industry; the Corporation’s inability to obtain continued approval from the AGLC and other necessary approvals required for the sales of its high potency THC branded “Fuego” vapes in the Province of Alberta ; the Corporation’s inability to successfully implement its strategy to expand market share in extract and extract derivatives while providing exceptional products to consumers ; the Corporation’s inability to meet the requirements necessary to remain listed on the OTCQB; and the inability of the Corporation to become the partner of choice for leading Canadian cannabis brands.
Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.
Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect the Corporation’s expectations as of the date hereof and are subject to change thereafter. The Corporation undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the United States Securities Act of 1933, as amended, and applicable state securities laws.
SOURCE Ayurcann Holdings Corp.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2022/31/c1951.html
News Provided by Canada Newswire via QuoteMedia

Ayurcann Holdings Corp. ( CSE: AYUR OTCQB: CDCLF FSE: 3ZQ0 ) (the ” Company “), a leading Canadian cannabis extraction company specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 products in the medical and recreational market, is pleased to provide an update to its exponential growth throughout Canada.
Ayurcann Market segments
Capacity of over 300,000 kg of EXTRACTION & REFINEMENT, We offer Extraction and Refinement services including Bulk Extraction, Winterization and Fractional Distillation.
Over 300 Kg of THC and CBD inventory available for BULK OIL SALES, Providing a gold standard quality of bulk oil for manufacturers and brands into medical and recreational.
Working with 10 national and international brands for WHITE LABEL Product development AND commercialization, we have the knowledge and experience to successfully bring products to market.
Results and Highlights
Ayurcann sold THC and CBD distillate containing over 1 billion milligrams of Cannabinoids into the Canadian market for Vapes, Tinctures, Topicals and Edibles, working with top selling brands throughout Canada.
Ayurcann entered Saskatchewan in Dec, with Fuego Vapes and Vida High potency Oils, now, #2 and #4 top selling Vapes in Saskatchewan* ( * ) Source: Headset
Ayurcann is entering and shipping into Ontario , Manitoba, Alberta, and New Brunswick, with the top selling Fuego Vapes, Vida Tinctures and Glow Topicals
Mr. Igal Sudman, CEO of Ayurcann, added: “We are thrilled to see our market penetration and revenues growing consistently. With new partnerships and board listings growing in various categories throughout Canada, we are proud to be one of the very few in our peer group showing consistent positive operating income we can confidently say that we fully expect to show continued profits, gain market share while building on our momentum.”
Mr. Sudman further commented on operational growth and entry into new markets; “we have increased bulk production up to 300,000 kilograms per year and have the ability to co-pack up to 3 million production products for the medicinal and recreational markets. We are confident in extracting value for our shareholders and gathering market share in the industry. We are confident that we will continue securing additional supply and manufacturing agreements with top-tier customers across the country, helping grow our top line revenues.”
About Ayurcann Holdings Corp.:
Ayurcann is a leading post-harvest solution provider with a focus on providing and creating custom processes and pharma grade products for the adult use and medical cannabis industry in Canada. Ayurcann is striving to become a partner of choice for leading Canadian and international cannabis brands by providing best-in-class, proprietary services including extraction, formulation, product development and custom manufacturing.
For additional information, please contact:
Ayurcann Holdings Corp.
Igal Sudman, CEO
905.492.3322
[email protected]
Investor Relations:
Email: [email protected]
Neither the CSE nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.
Certain statements included in this press release constitute forward-looking information or statements (collectively, ” forward-looking statements “), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward- looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward looking statements, including but not limited to statements relating to the Company’s expansion plans and future production capacity. These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties, and other factors.
Forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Factors that could cause the actual results to differ materially from those in forward-looking statements include, but are not limited to, failure to obtain regulatory approval, ability to increase production at the Company’s facilities, the continued availability of capital and financing, and general economic, market or business conditions. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, there can be no assurance that the statements will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, Further, there may be others that cause results not to be as anticipated, estimated or intended and such changes could be material. Public health crises, including the ongoing novel coronavirus (COVID-19) pandemic, could have significant economic and geopolitical impacts that may adversely affect the Company’s business, financial condition and/or results of operations. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Readers should not place undue reliance on the Company’s forward-looking statements.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the United States Securities Act of 1933, as amended, and applicable state securities laws.

News Provided by GlobeNewswire via QuoteMedia

Ayurcann Holdings Corp. ( CSE: AYUR OTCQB: CDCLF FSE: 3ZQ0 ) (the ” Company “), a leading Canadian cannabis extraction company specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 products in the medical and recreational market is pleased to announce the launch of their high potency THC branded “Fuego” vapes. Ayurcann will launch their line of Fuego products through the Ontario Cannabis Store (the “OCS”). Products will be made available through additional adult-use channels including authorized retailers across Ontario.
Ayurcann will be launching its best seller – Fuego’s Cherry Blossom. The vape product has been a best seller across various Canadian markets with repeat orders coming in on a monthly basis. With the introduction of one of the highest concentrations of active cannabinoids on the market in this format, Ayurcann’s strategy is to expand market share in extract and extract derivatives while providing exceptional products to consumers.
“We are thrilled to announce Fuego’s initial entrance into the largest Canadian market through the OCS, where we are optimistic about its market potential as an industry leading value brand line. We have been successfully selling in NB, MB, SK and believe that the interest from consumers and retailers will help set the standard for vape products in Ontario,” states Igal Sudman, CEO of Ayurcann.
About Ayurcann Holdings Corp.
Ayurcann is a leading post-harvest solution provider with a focus on providing and creating custom processes and pharma grade products for the adult use and medical cannabis industry in Canada. Ayurcann is striving to become a partner of choice for leading Canadian and international cannabis brands by providing best-in-class, proprietary services including extraction, formulation, product development and custom manufacturing.
For additional information, please contact:
Ayurcann Holdings Corp.
Igal Sudman, Chief Executive Officer
905-492-3322
[email protected]
Investor Relations:
Email: [email protected]
Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.
Certain statements included in this press release constitute forward-looking information or statements (collectively, ” forward-looking statements “), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward- looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward looking statements, including but not limited to statements relating to the Company’s expansion plans , future production capacity, the Company becoming a partner of choice for leading Canadian and international cannabis brands and the Company’s intended directors and auditor for the ensuing year . These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties, and other factors.
Forward-looking information in this news release are based on certain assumptions and expected future events, namely: the Company will expand and be able to maintain production capacity; the Company’s ability to continue as a going concern; continued approval of the Company’s activities by the relevant governmental and/or regulatory authorities; the continued growth of the Company ; the Company will become a partner of choice for leading Canadian and international cannabis brands ; and the Company will maintain the same directors and auditor for the ensuing year.
Forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Factors that could cause the actual results to differ materially from those in forward-looking statements include, but are not limited to, failure to obtain regulatory approval, ability to increase production at the Company’s facilities, the continued availability of capital and financing, general economic, market or business conditions , risk that the Company may not become a partner of choice for leading Canadian and international cannabis brands and risks that Company may change its directors and/or auditor prior to the next shareholder meeting . Forward-looking statements contained in this press release are expressly qualified by this cautionary statement. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, there can be no assurance that the statements will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended and such changes could be material. Public health crises, including the ongoing novel coronavirus (COVID-19) pandemic, could have significant economic and geopolitical impacts that may adversely affect the Company’s business, financial condition and/or results of operations. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.
Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the United States Securities Act of 1933, as amended, and applicable state securities laws.

News Provided by GlobeNewswire via QuoteMedia

Ayurcann Holdings Corp. ( CSE: AYUR OTCQB: CDCLF FSE: 3ZQ0 ) (the ” Company “), a leading Canadian cannabis extraction company specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 products in the medical and recreational market, is pleased to announce the results of voting at its annual general and special meeting of shareholders which was held on December 20, 2021 in Toronto, Ontario (the ” Meeting “).
All the resolutions, as described in the Company’s management information circular dated November 19, 2021, were approved by the requisite majority of votes cast at the Meeting. At the Meeting, the shareholders voted to: (i) fix the number of directors of the Company at five (5); (ii) reelect Igal Sudman, Roman Buzaker, Maor Shayit, David Hackett and Alison Gordon as directors of the Company for the ensuing year; (iii) and reappoint Clearhouse LLP as the auditors of the Company for the ensuing year.
RSU Grant
The Company is pleased to announce the granting of an aggregate of 785,405 restricted share units (each, an ” RSU “) to certain directors, officers, employees and consultants of the Company, pursuant to the Company’s RSU plan. All RSUs granted vest immediately and the common shares issuable upon redemption will be subject to a four (1) month and one (1) day hold period under applicable securities laws.
About Ayurcann Holdings Corp.
Ayurcann is a leading post-harvest solution provider with a focus on providing and creating custom processes and pharma grade products for the adult use and medical cannabis industry in Canada. Ayurcann is striving to become a partner of choice for leading Canadian and international cannabis brands by providing best-in-class, proprietary services including extraction, formulation, product development and custom manufacturing.
For additional information, please contact:
Ayurcann Holdings Corp.
Igal Sudman, Chief Executive Officer
905-492-3322
[email protected]
Investor Relations:
Email: [email protected]
Neither the Canadian Securities Exchange nor its Regulation Services Provider have reviewed or accept responsibility for the adequacy or accuracy of this release.
Certain statements included in this press release constitute forward-looking information or statements (collectively, ” forward-looking statements “), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward- looking statements are not historical facts but reflect current expectations regarding future results or events. This press release contains forward looking statements, including but not limited to statements relating to the Company’s expansion plans , future production capacity, the Company becoming a partner of choice for leading Canadian and international cannabis brands and the Company’s intended directors and auditor for the ensuing year . These forward-looking statements are based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties, and other factors.
Forward-looking information in this news release are based on certain assumptions and expected future events, namely: the Company will expand and be able to maintain production capacity; the Company’s ability to continue as a going concern; continued approval of the Company’s activities by the relevant governmental and/or regulatory authorities; the continued growth of the Company ; the Company will become a partner of choice for leading Canadian and international cannabis brands ; and the Company will maintain the same directors and auditor for the ensuing year.
Forward-looking statements are not guarantees of future performance and involve risks, uncertainties and assumptions which are difficult to predict. Factors that could cause the actual results to differ materially from those in forward-looking statements include, but are not limited to, failure to obtain regulatory approval, ability to increase production at the Company’s facilities, the continued availability of capital and financing, general economic, market or business conditions , risk that the Company may not become a partner of choice for leading Canadian and international cannabis brands and risks that Company may change its directors and/or auditor prior to the next shareholder meeting . Forward-looking statements contained in this press release are expressly qualified by this cautionary statement. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance, or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, there can be no assurance that the statements will prove to be accurate or that management’s expectations or estimates of future developments, circumstances or results will materialize. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended and such changes could be material. Public health crises, including the ongoing novel coronavirus (COVID-19) pandemic, could have significant economic and geopolitical impacts that may adversely affect the Company’s business, financial condition and/or results of operations. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.
Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the United States Securities Act of 1933, as amended, and applicable state securities laws.

News Provided by GlobeNewswire via QuoteMedia

Proprietary system seeks out and destroys airborne and surface-based mold, bacteria, viruses as well as Coronavirus and other pathogens in real-time
Mold contamination alone affects nearly 25% of the world’s crops
Hydroxyl technology capable of destroying E. coli, Salmonella, as well as other bacteria and other pathogens that present risk to consumers.
AGRIFORCE Growing Systems Ltd. (“the Company”) (NASDAQ: AGRI; AGRIW) an intellectual property (IP)-focused AgTech company dedicated to advancing sustainable cultivation and crop processing across multiple verticals, has entered into an exclusive worldwide licensing agreement with Radical Clean Solutions Ltd. (RCS), to commercialize their new proprietary hydroxyl generating devices within the controlled environment AGRIculture (CEA) and food manufacturing industries. The patent pending system seeks out and destroys both airborne and surface-based mold, bacteria, virus, odorous and volatile organic compounds (VOCs), as well as other pathogens and pollutants in real-time. The license grants the rights to AGRIFORCE in perpetuity as well as joint patent ownership rights for CEA.
Ingo Mueller, CEO of AgriFORCE Growing Systems, commented: “Adding to the momentum of our recent definitive agreement to acquire Delphy Groep BV (Delphy) (Delphy), we are thrilled to work with Radical Clean Solutions to start commercializing another set of solutions, which address some of the most important problem areas in the CEA and food manufacturing sectors. According to Food and Agricultural Organization (FAO) reports ( 1) , it is estimated that mycotoxin (mold) affects nearly 25% of the world’s crops. In addition to mold, airborne pathogens, such as COVID-19, contribute to significant loss of personnel due to sick leave, which is evident by the massive supply chain issues that have affected the industry during the current pandemic. Moreover, by destroying bacteria such as E. coli and Salmonella, manufacturers can potentially avoid costly recalls, which have both a financial and lasting brand impact.
Mueller continued, “Through the implementation of this technology, we believe our end users will not only improve their bottom line, but also better protect the safety of their employees and consumers. AgriFORCE is ideally suited to deploy this technology on a global scale by initially leveraging Delphy’s customer base, as well as the deep industry knowledge and relationships of their experienced management team. In addition, we look forward to deploying the system within our own GrowHouse facilities, which we believe will further enhance yields and improve profitability. Overall, this license agreement is closely aligned with our mission of delivering Clean, Green, Better AgTech.”
Roger M. Slotkin, CEO of Radical Clean Solutions, added: “We at RCS are proud to not only be a integral solution for AgriFORCE’s patented growing systems to ensure a mold and pathogen free environment, but also to have the opportunity to work directly with the seasoned management team of AgriFORCE as our exclusive, worldwide licensee for the marketing, sale and distribution of our products to the Controlled Environment Agriculture and food production/manufacturing industries. Unlike virtually all “air cleaning technologies” on the market today, the Radical solution does not simply filter or treat the air that passes through it. Our hydroxyl technology is dispersed throughout the environment in which it operates, thereby sanitizing all surfaces, materials, equipment and the very air itself. It does so through a natural, chemical-free process that is 100% harmless to people, pets and plants.”
(1)   Alshannaq A, Yu JH. Occurrence, toxicity, and analysis of major mycotoxins in food. International Journal of Environmental Research and Public Health. 2017;14(6):632. DOI: 10.3390/ijerph14060632

About Radical Clean Solutions Ltd
Radical Clean Solutions has developed an advanced product line consisting of “smart hydroxyl generation systems” focused on numerous industry verticals that is proven to eliminate 99.99+% of all pathogens, virus, mold, volatile organic compounds (VOCs) and allergy triggers. Applications for the system range from home, office, medical and senior care facilities to restaurants, transportation and more. Radical’s goal is to create a safe and healthy world, especially in light of the recent COVID pandemic.
About AgriFORCE
AGRIFORCE Growing Systems Ltd. (NASDAQ: AGRI; AGRIW) is an AgTech company focused on the development and acquisition of crop production know-how and intellectual property augmented by advanced AgTech facilities and solutions. Looking to serve the global market, the Company’s current focus is on North America, Europe and Asia. The AGRIFORCE vision is to be a leader in delivering plant-based foods and products through advanced and sustainable AgTech solution platforms that make positive change in the world—from seed to table. The AGRIFORCE goal: Clean. Green. Better. Additional information about AGRIFORCE is available at: www.AGRIforcegs.com.
Follow AgriFORCE on Twitter: @agriforcegs.
Follow AgriFORCE on Facebook: AgriFORCE Growing Systems Ltd.
Connect with AgriFORCE on LinkedIn: AgriFORCE Growing Systems Ltd.
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in our filings with the Securities and Exchange Commission and elsewhere. The Company undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.
Company Contact: (AgriForce)
Ian Pedersen
Tel: (604) 757-0952
Email: [email protected]
Company Contact : ( Radical Clean Solutions )
Roger M. Slotkin, CEO
Email: [email protected]
Investor Relations:
Crescendo Communications, LLC
David Waldman/Natalya Rudman
Tel: (212) 671-1021
Email: [email protected]
Media Relations:
AHA Creative Strategies Inc.
Ruth Atherley
Tel: (604) 846-8461
Email: [email protected]

News Provided by GlobeNewswire via QuoteMedia

GRAMMY® and Golden Globe® Award-nominated artist’s cannabis brand to launch in Florida exclusively at Trulieve this summer; partnership will extend to other markets in 2022
Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the United States today announced an exclusive partnership with multi-platinum-selling, GRAMMY® Award and Golden Globe® Award-nominated recording artist Wiz Khalifa’s brand, Khalifa Kush. Through the agreement, Trulieve becomes the exclusive producer, processor and retailer of Khalifa Kush branded products in Florida and other northeast markets, beginning this summer.

“We’re excited to partner with the undisputed leader in the Florida market,” said Wiz Khalifa . “Trulieve’s dedication to working with the community and creating an amazing customer experience perfectly lines up with our brand values, making them a great fit for our first expansion to the East Coast.”
Valda Coryat , Chief Marketing Officer of Trulieve, said, “Trulieve is committed to delivering a broad selection of the highest-quality cannabis brands to better serve our patient communities. Khalifa Kush is a respected brand known for top-tier genetics among cannabis connoisseurs. We look forward to becoming the exclusive home of the brand’s premium products in Florida and eventually in other markets.”
As the leading medical cannabis provider in Florida , the second largest medical cannabis market in the U.S., Trulieve offers the largest selection of THC and CBD products in a variety of delivery methods, including edibles, smokable flower, concentrates, tinctures, topical creams, vaporizers, and more. Trulieve also offers statewide home delivery, convenient online ordering, and in-store pickup.
For more information, please visit khalifakush.com and www.Trulieve.com .
About Khalifa Kush
Khalifa Kush products were first commercialized in the U.S. in 2015 by global icon Wiz Khalifa. The company has achieved continued growth and success by focusing on high quality and highly sought-after products in legalized cannabis markets. The Khalifa Kush brand offers a growing lineup of flower, pre-rolls, vapes, edibles, and concentrates, powered by proprietary genetics. Khalifa Kush is available in select markets including California, Nevada, Arizona and Utah. Learn more about our upcoming launches in Pennsylvania , Florida and Michigan and shop apparel at KHALIFAKUSH.COM .
About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S. operating in 11 states, with leading market positions in Arizona , Florida , and Pennsylvania . Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com .
Facebook: @Trulieve
Instagram: @Trulieve
Twitter: @Trulieve
Investor Contact
Christine Hersey , Director of Investor Relations
+1 (424) 202-0210
[email protected]
Media Contact
Rob Kremer , Executive Director of Corporate Communications
+1 (404) 218-3077
[email protected]
Khalifa Kush / Wiz Khalifa Contact
Dvora Englefield [email protected]
Courtni Asbury [email protected]
Chris Iacullo [email protected]
MATTIO Communications
[email protected]
View original content to download multimedia: https://www.prnewswire.com/news-releases/trulieve-announces-exclusive-partnership-with-khalifa-kush-301486728.html
SOURCE Trulieve Cannabis Corp.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/February2022/22/c2844.html
News Provided by Canada Newswire via QuoteMedia

A cannabis financial services firm will soon reach the public markets through a special purpose acquisition company (SPAC) merger worth US$185 million.
Last Monday (February 14), Northern Lights Acquisition (NASDAQ:NLIT) confirmed the terms through which it will combine with Safe Harbor Financial for a split payment of US$70 million in cash and US$115 million in shares.
Sundie Seefried, founder and CEO of Safe Harbor, will be the company’s front-facing executive. Safe Harbor, which is currently owned by subsidiary of Partner Colorado Credit Union, offers banking and financing solutions for cannabis corporations; this will be the core of the business and the driver of the public company.
In an interview with the Investing News Network (INN), Seefried said the SPAC method will allow the company to go public after being operational for seven years.
Safe Harbor offers financial services to cannabis companies in the US and has banked US$11 billion for cannabis businesses since its inception. The firm counts about 600 clients within its ranks, according to the executive.
“For us, it’s really about the growth of legalization, and the growth of the market and the opportunity that exists to serve it,” Seefried said.
The US cannabis marketplace is a testing ground that has faced nebulous and fractured regulations. Since the plant and related businesses are still considered illegal at the federal level, states have set up programs with their own rules and restrictions surrounding the drug.
This situation of state rules versus federal rules has left financing regulations in a bit of a gray area.
“Financial services have not kept pace with the industry growth, because financial institutions don’t want to move into the space as long as (cannabis is) federally illegal,” Seefried told INN.
In fact, she said that as of today, the company and its executives could be charged in the eyes of the federal rulebook. However, this doesn’t happen due to current market sentiment and growing cannabis acceptance.
The investment landscape has seen a quick rise in companies listing through the SPAC method.
SPACs are companies that raise money from investors and then go public with the intention of heading out into the market and merging with another business through what is known as a qualifying transaction. A deadline for the qualifying transaction is a part of the company’s launch, putting pressure on the business’ leaders to find a partner — money is returned to investors if a partner isn’t found before the deadline.
This trend hasn’t evaded the cannabis marketplace, with several companies using this mode of listing.

But despite their popularity, SPACs have had middling to poor results, causing many to become disenchanted.
The leaders of Northern Lights told the market that they see Safe Harbor as a scalable operation with a unique position in relation to potential future US cannabis policy changes.
“Safe Harbor is one of the only multi-state financial service organizations to successfully navigate the highly regulated cannabis banking industry, providing services that operators in other industries take for granted,” John Darwin and Joshua Mann, co-CEOs of Northern Lights, said.
After the merger was announced last Monday, the company closed the day at a year high of US$10.12 per share.
“Safe Harbor is the most compelling investment opportunity we have encountered in the cannabis industry as both operators and investors,” commented the executive duo from Northern Lights.
As of last Thursday (February 17), shares of the company were up 0.8 percent over a year-to-date period with a closing price of US$10.10.
When it comes to solutions for financing options and more uniform business options, Seefried told INN policies such as the SAFE Banking Act will offer relief in some forms, but shouldn’t be viewed as a one-time fix.
“(The SAFE Banking Act) isn’t going to solve the banking problem,” Seefried said. The executive explained this policy would really only remove the federal crime aspect of the cannabis business.
The policy would deem it permissible for Safe Harbor to conduct business as it already has been doing, but wouldn’t legalize the financing of this drug market.
Seefried pointed out that mixed messaging is inherent to the cannabis industry in the US.
“That’s the biggest barrier that will keep financial institutions from jumping in, because the resources necessary to build a bank’s secrecy function is extreme, and it’s expensive,” she said.
Seefried told INN the most important rules for a company like Safe Harbor to follow are performing extreme due diligence for its clients and following the money to guarantee legitimacy.
“I have to make sure that I know the company and its business well enough to make sure that money coming in is legitimate money, that it’s being taxed, that it’s being reported,” the executive said.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

The much-hyped cannabis beverage industry hasn’t exactly lived up to expectations. Even though it is finally showing significant signs of life, it still only represented about 2 percent of the industry last quarter. This brings it to about $100 million in California and probably about the same in Canada, the world’s two largest cannabis markets.
It turns out the problem is this: There’s never been anywhere to manufacture these drinks on a large scale, except for a couple of places in Canada backed by major liquor companies. Drinks in Canada have therefore enjoyed more market share than in the USA, as US consumers have had to endure the challenges of high-priced drinks of varying quality, made on rudimentary bottling lines.
The Tinley Beverage Company (CSE:TNY, OTC:TNYBF) struggled with this problem for years, searching California for reliable options to manufacture its premium, scientifically-advanced complex formulations, including Tinley’s #1 and #2 Emerald Cup award-winning drinks. Because major beverage alcohol companies have continued to steer clear of US cannabis manufacturing for legal reasons, the prospects for anyone building a major scaled cannabis bottling facility remained slim.
As a result, Tinley’s decided to take matters into its own hands: Tinley’s has built a world-class, scaled facility with the state’s most varied menu of product formulation, container type and packaging options for infused beverages. It intentionally built this facility far larger than it would need for its own Tinley’s brand cannabis beverages, recognizing the greater opportunity in manufacturing third-party products.
This has proven to be the right move for investors: Manufacturing consistently delivers far higher gross margins than the branded products themselves, without the high marketing costs and inventory risks. Of the $100 million of cannabis drinks being purchased in California, there’s a solid – if not majority – portion of this revenue being spent by these brands solely on manufacturing their products. Yet the margins are mostly going to the manufacturers, because co-packing is mostly a fixed cost business (i.e. the one-time cost to build the bottling lines). So who’s passing on that $100 million to investors – the brands or the manufacturers?
Until recently, there was just Tinley’s Long Beach facility and one other scaled licensed manufacturer in California focusing on third-party brands. With the other manufacturer having been acquired, and in the process of redirecting away from third-party brands to those of its new majority owner, Tinley’s is the only one, essentially with the market for third-party manufacturing beverages pretty much to itself. As a result, Tinley’s can continue to enjoy defensible gross margins until such time as another scaled manufacturer decides to enter the industry… typically a multi-year effort.
Tinley’s team is no stranger to co-packing beverages: Its founding investors and many executive members hail from Cott Corporation, until recently the world’s largest beverage co-manufacturer. If you’ve ever bought a supermarket soda brand, or many other beverage brands and product types, chances are it was manufactured by Cott.
Tinley’s vision is the same – if you purchase a cannabis beverage in California, there’s an increasingly large chance it was manufactured at Tinley’s facility. Will Tinley’s grow into the world’s largest cannabis beverage co-packer, just as Cott did for mainstream beverages? Well, this would take a bigger buildout because a separate bottling line would need to be built in each state until federal legalization occurs. However, California is the largest cannabis market in the USA, so Tinley’s can have become the USA’s largest cannabis beverage co-packing facility the meantime, and based on their clients’ feedback, it already is. Several of its clients have said they’ve never seen a facility anywhere nearly as large or high-quality as Tinley’s anywhere in the USA.
Tinley’s Long Beach facility can manufacture 12 million bottles, 10 million cans (imminently) and 7 million (and increasing) mini “shot” bottles per year, typically at $0.50-$1.20 per unit. Gross margins can well exceed 50 percent given the fixed cost nature of the business, making Tinley’s increasingly a cash cow. The bottle and can lines offer the seamless option of running the drinks through a tunnel pasteurizer – the only such equipment for cannabis in the USA – which enables more naturally formulated, preservative-free beverages, for additional fees. As of a few weeks ago, the company also offers a licensed distribution space, which significantly improves economics for Tinley’s and its clients, as mandatory state testing and the first-mile distribution processes can be completed on site.
All this is run by an all-star leadership team. In addition to past Cott leadership, the team includes Richard Gillis, who was previously the general manager of Coca-Cola’s US Southwest region. In this role, he oversaw 14 bottling lines, thousands of employees and US$2+ billion in revenue.
It’s been a long road – several years of struggling to manufacture its own drinks without any co-packers in the state – and then several years to build its own facility. All while burning cash and trying the patience of investors. This long road has proven to be a blessing in disguise for the company and those looking to invest. If it takes several years to build, commission, and optimize a bottling facility, this means it could be years until new entrants pop up, and Tinley’s will be operating with limited competition throughout this entire time.
The company continues to sell its own Tinley’s-branded products, two of which won the #1 and #2 awards at California’s Emerald Cup, the largest cannabis competition in the world. The Tinley’s line-up was crafted by alcohol formulators using non-alcoholic botanicals, flavors and spices that are found in the country’s leading spirits. These crafted concoctions are married with natural terpenes blended to the classic Pineapple Jack Sativa profile, and a micro dose of THC, with science to accelerate onset and deliver a full-flower effect. The margins on these products are still good and getting even better as volume increases. Margins should grow even further as Tinley’s joins forces with its co-packing clients to obtain volume discounts on common ingredients and packaging materials, and efficiently consolidates brands for last-mile distribution to licensed dispensaries and home delivery services.
However, the magic really happens in the third-party manufacturing, and Tinley might just have this portion of the market mostly to itself in a $100 million (and growing) category in the world’s largest cannabis market for the foreseeable future.
If you buy a cannabis beverage in California today, there’s a fairly good chance it was manufactured at Tinley’s. By the summer, there should be a very good chance that it was made in Tinley’s facility.
As a result, if you believe that there will be growth in the cannabis beverage category – whether to the US$2.8 billion projected by market research – or to a more moderate level – Tinley’s represents the best vehicle for investing in this trend. Why? Because it offers investors perhaps the highest margin function in the cannabis beverage industry, and does so for a highly diversified portfolio of drinks. In fact it probably offers investors exposure to the largest portfolio of beverages of any cannabis beverage company on the planet, given it derives economics from its own drinks plus those of its countless co-packing clients. Plus it’s a pure-play – Tinley’s isn’t affected by margins or industry changes in cultivation, retail, extraction, vapes, edibles or topicals.
Additionally, the products are expected to launch in Canada in Q2 this year. Tinley’s Canadian manufacturing partners have received purchase commitments from the Ontario Cannabis Store, which is perhaps the world’s largest single cannabis wholesale buyer, with exclusive distribution in over 1,000 stores. With the company having thousands of shareholders in Canada, these new products will enjoy a built-in network of customers and ambassadors to drive demand from day one.
At barely a $20 million market cap, there is plenty of room to participate in upside as the cannabis category – and Tinley’s portion of it – continues to grow. The time is now as more and more co-packing clients sign up and the company is beginning to report growing revenue and margins. Plus, potentially there are some new directions for growth given the company, for the first-time, added references to mergers and acquisitions, business development and expansion to other states in its recent materials. The buildup to the launch in Canada – with production beginning imminently – should boost attention to the stock considerably among its heavily Canadian-resident shareholder base.

Tinley’s operates the largest licensed cannabis bottling line in California designed for scalable third-party brand contract manufacturing. Services include a wide range of formulation, packaging, labelling options, as well as solutions for licensed warehousing and first-mile distribution. Its three manufacturing lines range from 7-12 million units per year capacity each, with key enhancements underway to accommodate contracted and anticipated demand.
A significant portion of California’s leading cannabis beverage brands are produced in Tinley’s facility, with co-packing clients continually being added.
*Pabst Brewing Company does not have a financial stake in Pabst Labs and will not share in the proceeds from cannabis-infused ‘Not Your Father’s Root Beer’ sales.
Cannabis-Infused products shown are manufactured by:
Lakewood Libations, Inc. Long Beach, California. CDPH Lic.10004047
The Company has entered into a purchase agreement to acquire all of the equity interests in Lakewood Libations, Inc. including the manufacturing and distribution licenses; the closing of this acquisition transaction is subject to certain standard conditions precedent including applicable regulatory approvals.
Tinley’s Emerald Cup award-winning branded cannabis products are sold in Cannabis dispensaries and home delivery services throughout California. They are crafted with distilled botanicals and natural extracts found in premium spirits, with cannabis rather than alcohol. The company also expects to begin delivering this line-up to Canadian markets in Q2 2022.
Richard Gillis was previously the president of Youngs Market Company, which valued at US$3 billion in annual sales and was the second-largest beverage alcohol distributor in Western USA. He was also the general manager and executive VP of Coca-Cola Enterprises in Southwest USA and has over 30 years in various senior positions in the beverage and CPG industries.
Ted served as President, Cott Corporation’s Retail Brands International, building profitable brand programs and contract packing relationships in traditional and new beverage and regulated categories around the world. Ted advises private equity and industry across consumer sectors on trends and opportunities, creating own-and licensed brand assets for retailers, manufacturers and IP owners.
Douglas Fulton is an LA-Based, international award-winning television executive & co-founder of LA Christine, a line of premium skincare products. He was also Executive VP, Europe, of SBS Broadcasting and NeuLion.
Ricky Talati, with graduate degrees in chemical engineering and management, was the senior commercialization manager, senior technical program manager and senior manager of supply chain integration at Pepsico Beverages.
Leaders to exchange ideas and discuss impact of cannabis in local communities regarding medical, economic, agricultural and expungement opportunities

Trulieve Cannabis Corp. (CSE: TRUL ) (OTCQX: TCNNF ) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., is excited to announce that it is hosting a Listening and Education Tour to exchange ideas with local community leaders. The programs center around the medical, economic, agricultural and expungement opportunities presented by the medical cannabis industry in Georgia . The first in-person event takes place at the Carolyn Harris Performing Arts Center in Adel on Friday, Feb. 25 at noon.
In July of 2021, the Georgia Access to Medical Cannabis Commission announced its intent to award Trulieve a Class 1 production license.
Moderated by Trulieve Georgia Chief Diversity Officer and Pro Football Hall of Famer Champ Bailey, the programs will feature numerous industry experts:
“As a Georgia native and current resident, I am thrilled to meet and inform others about the positive impacts that medical cannabis may provide,” said Bailey. “At each tour stop, Trulieve will seek to discover ways the company can work with community stakeholders make an impact on local support programs, as well as educate local leaders about the benefits of the medical cannabis industry.”
Expected in attendance will be state representatives, local government officials, religious and nonprofit leaders. The community at large is encouraged to attend and submit questions in advance via email at [email protected] . Following each session, the outcomes will be evaluated to determine the best way for Trulieve to make a positive impact on the community. Other locations and dates will be announced.
About Trulieve
Trulieve is an industry leading, vertically integrated cannabis company and multi-state operator in the U.S. operating in 11 states, with leading market positions in Arizona , Florida , and Pennsylvania . Trulieve is poised for accelerated growth and expansion, building scale in retail and distribution in new and existing markets through its hub strategy. By providing innovative, high-quality products across its brand portfolio, Trulieve delivers optimal customer experiences and increases access to cannabis, helping patients and customers to live without limits. Trulieve is listed on the CSE under the symbol TRUL and trades on the OTCQX market under the symbol TCNNF. For more information, please visit Trulieve.com .
Facebook: @Trulieve
Instagram: @Trulieve_
Twitter: @Trulieve
Investor Contact
Christine Hersey , Director of Investor Relations
+1 (424) 202-0210
[email protected]
Media Contact
Rob Kremer , Executive Director of Corporate Communications
+1 (404) 218-3077
[email protected]
Rhythm Communications
Amy Parrish
+1 (404) 310-6559
[email protected]
View original content: https://www.prnewswire.com/news-releases/trulieve-georgia-to-host-listening-and-education-statewide-tour-moderated-by-champ-bailey-and-industry-experts-301486367.html
SOURCE Trulieve Cannabis Corp.

View original content: http://www.newswire.ca/en/releases/archive/February2022/21/c3649.html
News Provided by Canada Newswire via QuoteMedia

If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
WeissLaw LLP
305 Broadway, 7th Floor
New York, NY 10007
(212) 682-3025
(888) 593-4771
[email protected]

SLR Senior Investment Corp. (NASDAQ: SUNS)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of SLR Senior Investment Corp. (NASDAQ: SUNS) in connection with the proposed merger of SUNS with SLR Investment Corp. (“SLRC”).  Pursuant to the agreement, SUNS shareholders will receive an amount of SLRC shares with a net asset value (“NAV”) equal to the NAV of SUNS shares that they hold at the time of closing.  Upon closing, current SUNS shareholders will own approximately 22.8% of the combined company.  If you own SUNS shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/suns
Enterprise Diversified, Inc. (OTC: SYTE)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Enterprise Diversified, Inc. (OTC: SYTE) , in connection with SYTE’s proposed merger with CrossingBridge Advisors, LLC (“CrossingBridge”).  Under the agreement, SYTE and CrossingBridge will become wholly owned subsidiaries of a newly formed holding company, ENDI Corp.  The outstanding securities of SYTE and CrossingBridge will be exchanged for common stock of ENDI Corp., resulting in SYTE stockholders owning 52.5% of ENDI Corp.  If you own SYTE shares and wish to discuss this investigation or your rights, please call or visit our website: https://www.weisslaw.co/news-and-cases/syte
Goodness Growth Holdings, Inc. (OTCQX: GDNSF)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Goodness Growth Holdings, Inc. (OTCQX: GDNSF) , in connection with the proposed acquisition of the company by Verano Holdings Corp. (“Verano”).  Under the terms of the agreement, each holder of GDNSF subordinate voting shares will receive 0.22652 of a Verano Class A subordinate voting share (a ” Verano Share “) for each share held and each holder of GDNSF multiple voting shares and GDNSF super voting shares will receive 22.652 Verano Shares for each respective share held.  If you own GDNSF shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/gdnsf
Activision Blizzard, Inc. (NASDAQ: ATVI)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Activision Blizzard, Inc. (NASDAQ: ATVI) , in connection with the proposed acquisition of ATVI by Microsoft Corporation.  Under the terms of the agreement, ATVI shareholders will receive $95.00 in cash for each share of ATVI common stock that they hold.  If you own ATVI shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/atvi
View original content to download multimedia: https://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-reminds-suns-syte-gdnsf-and-atvi-shareholders-about-its-ongoing-investigations-301485923.html
SOURCE WeissLaw LLP
News Provided by PR Newswire via QuoteMedia

Investing News Network websites or approved third-party tools use cookies. Please refer to the  cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies. 

source

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article